Class information for:
Level 1: CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
24888 298 36.1 93%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
10 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 134299
140 2             IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY 23462
24888 1                   CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE 298

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANC VACCINE DEV address 2442561 14% 57% 42
2 INNOVAT CANC THER Y address 1979349 29% 23% 85
3 PERSONALIZED PEPTIDE VACCINE authKW 853890 3% 83% 10
4 IMMUNOL IMMUNOTHER Y address 528469 9% 18% 28
5 CANC VACCINE address 500029 12% 14% 35
6 PEPTIDE VACCINE authKW 499144 12% 13% 37
7 SART3 authKW 461099 2% 75% 6
8 ONCOANTIGEN authKW 327893 1% 80% 4
9 PEPTIDE COCKTAIL authKW 307402 1% 100% 3
10 HLA A24 authKW 266394 4% 20% 13

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 5108 67% 0% 199
2 Immunology 516 21% 0% 63
3 Medicine, Research & Experimental 162 10% 0% 29
4 Urology & Nephrology 87 6% 0% 17
5 Cell & Tissue Engineering 12 1% 0% 2
6 Endocrinology & Metabolism 11 4% 0% 11
7 Cell Biology 5 4% 0% 13
8 Pathology 1 1% 0% 4
9 Virology 1 1% 0% 3
10 Gastroenterology & Hepatology 1 1% 0% 4

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANC VACCINE DEV 2442561 14% 57% 42
2 INNOVAT CANC THER Y 1979349 29% 23% 85
3 IMMUNOL IMMUNOTHER Y 528469 9% 18% 28
4 CANC VACCINE 500029 12% 14% 35
5 GENET CLIN ONCOL 204934 1% 100% 2
6 KURUME UNIV INNOVAT CANC THER Y 184439 1% 60% 3
7 21ST CENTURY COE PROGRAM MED SCI 156892 2% 22% 7
8 CANC VACCINES 153698 1% 50% 3
9 SURG BIOENGNMINATO KU 115272 1% 38% 3
10 COE INNOVAT CANC THER Y 102467 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER SCIENCE 31699 11% 1% 33
2 CANCER IMMUNOLOGY IMMUNOTHERAPY 5296 5% 0% 15
3 ONCOIMMUNOLOGY 5244 2% 1% 7
4 INTERNATIONAL JOURNAL OF ONCOLOGY 5196 7% 0% 22
5 JOURNAL OF IMMUNOTHERAPY 3888 3% 0% 8
6 CLINICAL CANCER RESEARCH 3328 7% 0% 22
7 PROSTATE 2717 4% 0% 11
8 JOURNAL OF TRANSLATIONAL MEDICINE 1584 2% 0% 6
9 ONCOLOGY REPORTS 1474 4% 0% 12
10 JOURNAL OF IMMUNOLOGY RESEARCH 1130 1% 0% 3

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 PERSONALIZED PEPTIDE VACCINE 853890 3% 83% 10 Search PERSONALIZED+PEPTIDE+VACCINE Search PERSONALIZED+PEPTIDE+VACCINE
2 PEPTIDE VACCINE 499144 12% 13% 37 Search PEPTIDE+VACCINE Search PEPTIDE+VACCINE
3 SART3 461099 2% 75% 6 Search SART3 Search SART3
4 ONCOANTIGEN 327893 1% 80% 4 Search ONCOANTIGEN Search ONCOANTIGEN
5 PEPTIDE COCKTAIL 307402 1% 100% 3 Search PEPTIDE+COCKTAIL Search PEPTIDE+COCKTAIL
6 HLA A24 266394 4% 20% 13 Search HLA+A24 Search HLA+A24
7 KIF20A 234207 1% 57% 4 Search KIF20A Search KIF20A
8 TIP110 230550 1% 75% 3 Search TIP110 Search TIP110
9 CANCER PEPTIDE VACCINE 204934 1% 100% 2 Search CANCER+PEPTIDE+VACCINE Search CANCER+PEPTIDE+VACCINE
10 CELL DIVISION CYCLE ASSOCIATED PROTEIN 1 204934 1% 100% 2 Search CELL+DIVISION+CYCLE+ASSOCIATED+PROTEIN+1 Search CELL+DIVISION+CYCLE+ASSOCIATED+PROTEIN+1

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 NOGUCHI, M , SASADA, T , ITOH, K , (2013) PERSONALIZED PEPTIDE VACCINATION: A NEW APPROACH FOR ADVANCED CANCER AS THERAPEUTIC CANCER VACCINE.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 62. ISSUE 5. P. 919-929 43 74% 10
2 SAKAMOTO, S , NOGUCHI, M , YAMADA, A , ITOH, K , SASADA, T , (2016) PROSPECT AND PROGRESS OF PERSONALIZED PEPTIDE VACCINATIONS FOR ADVANCED CANCERS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 16. ISSUE 5. P. 689 -698 41 52% 1
3 NOGUCHI, M , MINE, T , KOMATSU, N , SUEKANE, S , MORIYA, F , MATSUOKA, K , YUTANI, S , SHICHIJO, S , YAMADA, A , TOH, U , ET AL (2010) ASSESSMENT OF IMMUNOLOGICAL BIOMARKERS IN PATIENTS WITH ADVANCED CANCER TREATED BY PERSONALIZED PEPTIDE VACCINATION.CANCER BIOLOGY & THERAPY. VOL. 10. ISSUE 12. P. 1266 -1279 31 76% 2
4 DAIGO, Y , TAKANO, A , TERAMOTO, K , CHUNG, S , NAKAMURA, Y , (2013) A SYSTEMATIC APPROACH TO THE DEVELOPMENT OF NOVEL THERAPEUTICS FOR LUNG CANCER USING GENOMIC ANALYSES.CLINICAL PHARMACOLOGY & THERAPEUTICS. VOL. 94. ISSUE 2. P. 218-223 32 62% 6
5 TERASAKI, M , SHIBUI, S , NARITA, Y , FUJIMAKI, T , AOKI, T , KAJIWARA, K , SAWAMURA, Y , KURISU, K , MINETA, T , YAMADA, A , ET AL (2011) PHASE I TRIAL OF A PERSONALIZED PEPTIDE VACCINE FOR PATIENTS POSITIVE FOR HUMAN LEUKOCYTE ANTIGEN-A24 WITH RECURRENT OR PROGRESSIVE GLIOBLASTOMA MULTIFORME.JOURNAL OF CLINICAL ONCOLOGY. VOL. 29. ISSUE 3. P. 337-344 23 82% 21
6 SASADA, T , YAMADA, A , NOGUCHI, M , ITOH, K , (2014) PERSONALIZED PEPTIDE VACCINE FOR TREATMENT OF ADVANCED CANCER.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 21. P. 2332 -2345 45 40% 4
7 KOINUMA, J , AKIYAMA, H , FUJITA, M , HOSOKAWA, M , TSUCHIYA, E , KONDO, S , NAKAMURA, Y , DAIGO, Y , (2012) CHARACTERIZATION OF AN OPA INTERACTING PROTEIN 5 INVOLVED IN LUNG AND ESOPHAGEAL CARCINOGENESIS.CANCER SCIENCE. VOL. 103. ISSUE 3. P. 577-586 30 61% 10
8 UEMURA, H , FUJIMOTO, K , MINE, T , UEJIMA, S , DE VELASCO, MA , HIRAO, Y , KOMATSU, N , YAMADA, A , ITOH, K , (2010) IMMUNOLOGICAL EVALUATION OF PERSONALIZED PEPTIDE VACCINATION MONOTHERAPY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER.CANCER SCIENCE. VOL. 101. ISSUE 3. P. 601 -608 22 85% 8
9 YAJIMA, N , YAMANAKA, R , MINE, T , TSUCHIYA, N , HOMMA, J , SANO, M , KURAMOTO, T , OBATA, Y , KOMATSU, N , ARIMA, Y , ET AL (2005) IMMUNOLOGIC EVALUATION OF PERSONALIZED PEPTIDE VACCINATION FOR PATIENTS WITH ADVANCED MALIGNANT GLIOMA.CLINICAL CANCER RESEARCH. VOL. 11. ISSUE 16. P. 5900-5911 27 68% 85
10 KOBAYASHI, Y , TAKANO, A , MIYAGI, Y , TSUCHIYA, E , SONODA, H , SHIMIZU, T , OKABE, H , TANI, T , FUJIYAMA, Y , DAIGO, Y , (2014) CELL DIVISION CYCLE-ASSOCIATED PROTEIN 1 OVEREXPRESSION IS ESSENTIAL FOR THE MALIGNANT POTENTIAL OF COLORECTAL CANCERS.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 44. ISSUE 1. P. 69 -77 28 57% 3

Classes with closest relation at Level 1


Rank Class id link
1 13629 TUMOR IMMUNOL BIOL//SIPULEUCEL T//5T4
2 1375 CANCER TESTIS ANTIGEN//NY ESO 1//MAGE
3 25112 GV1001//PA MSHA VACCINE//HTERTC27
4 25169 IMP3//CRD BP//KOC
5 26564 RAS DERIVED PEPTIDES//P53 PEPTIDES//RAS PEPTIDES
6 16780 CANC VACCINE DEV PROGRAM//CANC IMMUNOL IMMUNOTHER Y//TUMOR VACCINE GRP
7 26911 ENDOSIALIN//CD248//ENDOTHELIAL LIKE DIFFERENTIATION
8 34184 IEX 1//IMMEDIATE EARLY GENE X 1 IEX 1//IMMEDIATE EARLY RESPONSE GENE 3
9 10486 IMMUNOINFORMATICS//EPITOPE PREDICTION//COMPUTATIONAL VACCINOLOGY
10 17632 GLYPICAN 3//GPC3//SIMPSON GOLABI BEHMEL SYNDROME

Go to start page